Resources
Regulatory Guidance & Policy
Guidance for best practices for clinical trials
Clinical Trials Information System: Training and Support
Commercial Clinical Trials in the UK: the Lord O’Shaughnessy review – Final Report
European Medical Agency (EMA)- Clinical Trials Regulation
Real-world evidence for regulatory decision-making: updated guidance from around the world
Global Partnerships
Global system for cancer drug testing and approval is needed
Reimagining Patient-Centric Cancer Clinical Trials: A Multi-Stakeholder International Coalition
IQVA Commitment to Global Health
Gates Foundation to Accelerate mRNA Vaccine Innovation and Manufacturing in Africa and Globally
Oncology Quality, Characterization and Assessment of Real-World Data (QCARD) Initiative
Global Initiatives
Project Orbis: Global Collaborative Review Program
Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria
Expanding access to lung cancer clinical trials by reducing the use of restrictive exclusion criteria: perspectives of a Multistakeholder Working Group
A new approach to simplifying and harmonizing cancer clinical trials-standardizing eligibility criteria